NCT00112073

Data

{
  "briefSummary": "The purpose of this study is to assess the safety and tolerability of multiple doses of AAB-001 passive immunization in patients with mild to moderate Alzheimer's disease (AD).",
  "completionDate": "2008-12",
  "conditions": [
    "Alzheimer's Disease"
  ],
  "enrollmentCount": 234,
  "enrollmentType": "ACTUAL",
  "nctId": "NCT00112073",
  "phase": "PHASE2",
  "sponsorId": "janssen-alzheimer-immunotherapy-research-development-llc",
  "startDate": "2005-04",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "A Phase IIA, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, and Immunogenicity Trial of AAB-001 in Patients With Mild to Moderate AD",
  "url": "https://clinicaltrials.gov/study/NCT00112073"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version